Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2026-01-14 @ 1:44 AM
Study NCT ID:
NCT00983528
Status:
TERMINATED
Last Update Posted:
2020-08-12
First Post:
2009-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor:
University of California, San Diego
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-23
First Submit QC Date:
None
Study First Post Date:
2009-09-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-23
Results First Submit QC Date:
None
Results First Post Date:
2020-08-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-29
Last Update Post Date:
2020-08-12
Last Update Post Date Type:
ACTUAL